THC THERAPEUTICS, INC.: 10-Q filed 2013-06-11

Name: THC THERAPEUTICS, INC.: 10-Q filed 2013-06-11
Creator: THC THERAPEUTICS, INC.

What THC THERAPEUTICS, INC. reported in its quarterly report filed 2013-06-11 (fiscal Q3 2013): 17 published measures, 47 facts as tagged in accession 0001255294-13-000424.

This filing

Form: 10-Q (quarterly report)
Filed: 2013-06-11
Fiscal period: fiscal Q3 2013
Accession: 0001255294-13-000424 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All THC THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2013-04-30	553,896	USD
At 2012-07-31	595,393	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2013-04-30	439,180	USD
At 2012-07-31	389,381	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2013-04-30	114,716	USD
At 2012-07-31	206,012	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2013-02-01 to 2013-04-30	-20,302	USD	89
2012-08-01 to 2013-04-30	-91,296	USD	273
2007-05-01 to 2013-04-30	-480,219	USD	2192
2012-02-01 to 2012-04-30	-10,795	USD	90
2011-08-01 to 2012-04-30	-14,895	USD	274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2012-08-01 to 2013-04-30	-93,997	USD	273
2007-05-01 to 2013-04-30	-454,722	USD	2192
2011-08-01 to 2012-04-30	-9,496	USD	274

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2007-05-01 to 2013-04-30	200	USD	2192

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2012-08-01 to 2013-04-30	46,667	USD	273
2007-05-01 to 2013-04-30	638,838	USD	2192
2011-08-01 to 2012-04-30	440,000	USD	274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2012-08-01 to 2013-04-30	-3,365	USD	273
2007-05-01 to 2013-04-30	-178,365	USD	2192
2011-08-01 to 2012-04-30	-175,000	USD	274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2013-04-30	28,896	USD
At 2012-07-31	70,393	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2013-02-01 to 2013-04-30	750	USD	89
2012-08-01 to 2013-04-30	1,000	USD	273
2007-05-01 to 2013-04-30	3,764	USD	2192
2012-02-01 to 2012-04-30	300	USD	90
2011-08-01 to 2012-04-30	900	USD	274

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2013-04-30	264,180	USD
At 2012-07-31	214,381	USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2013-04-30	282,489	USD
At 2012-07-31	282,489	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2013-04-30	38,180	USD
At 2012-07-31	39,381	USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

Period	Value	Unit	Days
At 2013-04-30	0	USD
At 2012-07-31	0	USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2012-08-01 to 2013-04-30	-91,296	USD	273
2007-05-01 to 2013-04-30	-480,219	USD	2192
2011-08-01 to 2012-04-30	-14,895	USD	274

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2013-02-01 to 2013-04-30	9,224	USD	89
2012-08-01 to 2013-04-30	18,363	USD	273
2007-05-01 to 2013-04-30	39,604	USD	2192
2012-02-01 to 2012-04-30	6,295	USD	90
2011-08-01 to 2012-04-30	6,295	USD	274

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2012-08-01 to 2013-04-30	0	USD	273
2007-05-01 to 2013-04-30	581,225	USD	2192
2011-08-01 to 2012-04-30	500,000	USD	274

Inspect the source

Entity: THC THERAPEUTICS, INC. / CIK 0001404935
Captured: 2026-09-21T17:18:57.388Z
SEC response SHA-256: f4626d642848143dc14fec3fdbe81fdaf088917037c5da7ecb43246b70ad052b

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001404935.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))